20Feb
HHS Proposed Guidance Would Clarify Rules for Drug Manufacturer Coupons
The Department of Health and Human Services (HHS) revisited the treatment of prescription drug manufacturer coupons in a proposed rule, published on February 6, 2020, that could be welcome news for employers that have been struggling to interpret...
By:
Ogletree, Deakins, Nash, Smoak & Stewart,
Source Url: https://www.jdsupra.com/legalnews/hhs-proposed-guidance-would-clarify-14582/
Related
Antitrust enforcers in the United States and European Union (EU) remained active in 2019, and recent...
Read More >
Prior to the advent of social media and especially the #MeToo movement, employers were generally com...
Read More >
On June 7, 2019, in Altera Corp. v. Commissioner, a reconstituted panel of the U.S. Court of Appeals...
Read More >
Employers in Ontario will likely welcome the decision in Katz et al. v. Clarke, 2019 ONSC 2188 (Divi...
Read More >
The Justice Department lost another merger the other day. This one was their challenge to Sabre’s ...
Read More >
Seyfarth Synopsis: On Wednesday, the Chicago City Council passed the Chicago Fair Workweek Ordinance...
Read More >